Mirage News14h
New Strategies Emerge for Rare Bladder Disease Treatment
Despite its increasing prevalence, a painful condition called bladder pain syndrome, or interstitial cystitis, remains understudied with limited ...
argenx (NASDAQ:ARGX) Given New $1,100.00 Price Target at Guggenheim
(NASDAQ:ARGX – Free Report) had its price target increased by Guggenheim from $775.00 to $1,100.00 in a report released on Monday morning,Benzinga reports. They currently have a buy rating on the ...
argenx SE (NASDAQ:ARGX) Receives $662.83 Consensus Target Price from Brokerages
SE (NASDAQ:ARGX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-two analysts that are currently covering the company, Marketbeat reports. One analyst has ...
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Genetic analysis explains rare disease severity, points to possible treatment
Researchers at Washington University School of Medicine in St. Louis have uncovered why some patients with a rare genetic ...